The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team' [Fortune]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Fortune
I recently sat down with Juliette Han, the CFO and COO at Cambrian Bio, a clinical-stage biotechnology company developing a pipeline of therapeutics to treat diseases that come with age. Han is also an adjunct professor in finance at Columbia Business School. But a career path combining science and finance wasn't one that she initially expected. “I really could not stand science when I was in high school,” Han told me. “I thought you just memorize a bunch of stuff, take a test, and there's a right and wrong answer. That was not that interesting to me.” When Han signed up for a general biology course in college taught by a neuroscientist, however, she encountered a whole new world. “I felt like with neuroscience anything was possible,” she said. “The more you find out, the more questions you have. It's so complex that it's really humbling.” Han would continue that path, eventually earning a Ph.D. in neuroscience from Harvard Medical School. The business world soon came calling,
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy [BNN Bloomberg (Canada)]BNN Bloomberg
- The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control [Yahoo! Finance]Yahoo! Finance
- Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Stanley Druckenmiller makes surprising small-cap and AI stock bet [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- LLY's page on the SEC website